On January 13, 2021 Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, reported that Dr. Amit Kumar, Anixa’s Chief Executive Officer, will present at B. Riley’s Inaugural Oncology Investor Conference to be held January 20-21, 2021 (Press release, Anixa Biosciences, JAN 13, 2021, View Source [SID1234573952]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Dr. Kumar will participate in a fireside chat presentation to discuss Anixa’s recent accomplishments and anticipated milestones. Company management will also be available to participate in online one-on-one meetings with investors who are registered to attend the conference.
Anixa’s presentation will be live webcast at 10:30 a.m. PST on January 21, 2021. The presentation will be open to registered conference attendees, institutional investors and investor relations professionals, who may register to view the live webcast at https://b-riley-oncology-investor-conference.events.issuerdirect.com/signup. After completion of the event, a replay of the presentation will be publicly available on the Anixa website at View Source